![](/img/cover-not-exists.png)
Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial
Sharma, Abhinav, de Souza Brito, Flávio, Sun, Jie-Lena, Thomas, Laine, Haffner, Steven, Holman, Rury R., Lopes, Renato D.Volume:
186
Language:
english
Journal:
American Heart Journal
DOI:
10.1016/j.ahj.2016.12.011
Date:
April, 2017
File:
PDF, 732 KB
english, 2017